Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +13 vs. previous quarter
- 24
- 13F valueReported value at the end of Q2 2026
- $736.8K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ENVB, Q2 2026
No superinvestor reported holding ENVB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Enveric Biosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Pasqualone FrankDirector | PPurchase | +1.00K | $2.14 | +$2.14K | New position1.00K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Enveric Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sio Capital Management, LLC | 180,000 | $248.4K | 0.04% | +180,000 | New |
| Ikarian Capital, LLC | 100,002 | $138.0K | 0.02% | +100,002 | New |
| AdvisorShares Investments LLC | 35,417 | $48.9K | 0.01% | +18,443+108.7% | Added |
| Renaissance Technologies LLC | 32,058 | $44.2K | 0.00% | +32,058 | New |
| Armistice Capital, LLC | 32,000 | $44.2K | 0.00% | +32,000 | New |
| Boothbay Fund Management, LLC | 30,142 | $41.6K | 0.00% | +30,142 | New |
| XTX Topco Ltd | 18,990 | $26.2K | 0.00% | +18,990 | New |
| StoneX Group Inc. | 11,814 | $21.9K | 0.00% | +11,814 | New |
| HRT Financial LP | 15,458 | $21.0K | 0.00% | +15,458 | New |
| Vanguard Capital Management LLC | 14,912 | $20.6K | 0.00% | +14,912 | New |